KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Debt to Equity (2016 - 2023)

Medpace Holdings' Debt to Equity history spans 7 years, with the latest figure at $0.14 for Q2 2023.

  • For Q2 2023, Debt to Equity fell 92.02% year-over-year to $0.14; the TTM value through Jun 2023 reached $0.14, down 92.02%, while the annual FY2022 figure was $0.13, N/A changed from the prior year.
  • Debt to Equity reached $0.14 in Q2 2023 per MEDP's latest filing, down from $0.33 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.76 in Q2 2022 to a low of $0.09 in Q1 2019.
  • Average Debt to Equity over 3 years is $0.48, with a median of $0.24 recorded in 2023.
  • Peak YoY movement for Debt to Equity: tumbled 76.1% in 2019, then tumbled 92.02% in 2023.
  • A 3-year view of Debt to Equity shows it stood at $0.09 in 2019, then skyrocketed by 44.27% to $0.13 in 2022, then increased by 8.69% to $0.14 in 2023.
  • Per Business Quant, the three most recent readings for MEDP's Debt to Equity are $0.14 (Q2 2023), $0.33 (Q1 2023), and $0.13 (Q4 2022).